Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Clene (CLNN).
On February 29, 2024, the Company revealed exciting clinical results for its CNM-Au8 30mg treatment at the prestigious ACTRIMS Forum, showcasing the potential of this new therapy in the VISIONARY-MS trial long-term extension. This announcement, expected to intrigue investors and those tracking advancements in MS treatment, was also officially released to the public through a detailed press statement.
For detailed information about CLNN stock, go to TipRanks’ Stock Analysis page.